Jeffrey How

1.3k total citations
57 papers, 841 citations indexed

About

Jeffrey How is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, Jeffrey How has authored 57 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Obstetrics and Gynecology, 23 papers in Reproductive Medicine and 21 papers in Oncology. Recurrent topics in Jeffrey How's work include Endometrial and Cervical Cancer Treatments (25 papers), Ovarian cancer diagnosis and treatment (17 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Jeffrey How is often cited by papers focused on Endometrial and Cervical Cancer Treatments (25 papers), Ovarian cancer diagnosis and treatment (17 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Jeffrey How collaborates with scholars based in United States, Canada and United Kingdom. Jeffrey How's co-authors include Walter H. Gotlieb, Susie Lau, Raphael Gotlieb, Joshua Z. Press, Sonya Brin, Jeremie Abitbol, Stephan Probst, Alex Ferenczy, Manuela Pelmus and Shannon Salvador and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Jeffrey How

50 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey How United States 17 579 416 210 179 140 57 841
Joel Clemmer United States 16 641 1.1× 643 1.5× 265 1.3× 169 0.9× 194 1.4× 40 949
Marika C. Stenfert Kroese Netherlands 10 684 1.2× 529 1.3× 138 0.7× 148 0.8× 176 1.3× 14 902
Neil S. Horowitz United States 17 680 1.2× 512 1.2× 161 0.8× 187 1.0× 103 0.7× 29 854
Alessia Aloisi Italy 22 638 1.1× 623 1.5× 314 1.5× 150 0.8× 143 1.0× 56 1.1k
Marilyn Huang United States 16 437 0.8× 295 0.7× 211 1.0× 115 0.6× 229 1.6× 96 802
Stephanie L. Wethington United States 21 554 1.0× 484 1.2× 206 1.0× 139 0.8× 307 2.2× 67 1.0k
Nicolò Bizzarri Italy 19 815 1.4× 618 1.5× 284 1.4× 274 1.5× 251 1.8× 158 1.2k
N.R. Abu-Rustum United States 11 452 0.8× 410 1.0× 221 1.1× 179 1.0× 181 1.3× 30 748
Shannon Salvador Canada 18 580 1.0× 621 1.5× 207 1.0× 131 0.7× 143 1.0× 74 959
Nawar Latif United States 14 372 0.6× 390 0.9× 176 0.8× 104 0.6× 167 1.2× 101 774

Countries citing papers authored by Jeffrey How

Since Specialization
Citations

This map shows the geographic impact of Jeffrey How's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey How with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey How more than expected).

Fields of papers citing papers by Jeffrey How

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey How. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey How. The network helps show where Jeffrey How may publish in the future.

Co-authorship network of co-authors of Jeffrey How

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey How. A scholar is included among the top collaborators of Jeffrey How based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey How. Jeffrey How is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stephen, Bettzy, Jeffrey How, Justin T. Moyers, et al.. (2025). Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial. PubMed. 8(2). 143–151. 1 indexed citations
2.
Hajjar, Joud, Bettzy Stephen, Serdar A. Gurses, et al.. (2025). Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors. ESMO Open. 10(8). 105518–105518. 1 indexed citations
3.
Gouda, Mohamed A., Bettzy Stephen, Yanyan Tian, et al.. (2024). A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma. SHILAP Revista de lepidopterología. 7(4). 247–254. 2 indexed citations
4.
How, Jeffrey, Bryan Fellman, Michael Frumovitz, et al.. (2024). Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors. American Journal of Obstetrics and Gynecology. 230(5). 544.e1–544.e13. 5 indexed citations
5.
How, Jeffrey, Amir A. Jazaeri, Shannon N. Westin, et al.. (2024). Translating biological insights into improved management of endometrial cancer. Nature Reviews Clinical Oncology. 21(11). 781–800. 9 indexed citations
6.
How, Jeffrey, Shannon N. Westin, Lois M. Ramondetta, et al.. (2023). Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors. American Journal of Obstetrics and Gynecology. 228(6). 724.e1–724.e9. 8 indexed citations
7.
8.
Rauh‐Hain, J. Alejandro, Ross Harrison, Jeffrey How, et al.. (2023). Exceptional Response to Pembrolizumab for Treatment of Metastatic Chemorefractory Endometrial Carcinoma in a Patient with Lynch Syndrome: A Case Report. SHILAP Revista de lepidopterología. 16(1). 279–284. 1 indexed citations
9.
Wang, Tianci, et al.. (2021). The role of digital patient education in maternal health: A systematic review. Patient Education and Counseling. 105(3). 586–593. 20 indexed citations
10.
How, Jeffrey, Bryan Fellman, Karen H. Lu, et al.. (2021). Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer. Gynecologic Oncology. 162(1). 24–31. 31 indexed citations
11.
Kogan, Liron, Emad Matanes, Michel D. Wissing, et al.. (2020). The added value of sentinel node mapping in endometrial cancer. Gynecologic Oncology. 158(1). 84–91. 19 indexed citations
12.
Gotlieb, Raphael, Jeremie Abitbol, Jeffrey How, et al.. (2019). Gender differences in how physicians access and process information. Gynecologic Oncology Reports. 27. 50–53. 13 indexed citations
13.
Kessous, Roy, Jeffrey How, Jeremie Abitbol, et al.. (2019). Triple tracer (blue dye, indocyanine green, and Tc99) compared to double tracer (indocyanine green and Tc99) for sentinel lymph node detection in endometrial cancer: a prospective study with random assignment. International Journal of Gynecological Cancer. 29(7). 1121–1125. 12 indexed citations
14.
Wissing, Michel D., Cristina Mitric, Jeremie Abitbol, et al.. (2019). Risk factors for lymph nodes involvement in obese women with endometrial carcinomas. Gynecologic Oncology. 155(1). 27–33. 12 indexed citations
15.
Abitbol, Jeremie, Walter H. Gotlieb, Agnihotram V. Ramanakumar, et al.. (2019). Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy. International Journal of Gynecological Cancer. 29(9). 1341–1347. 31 indexed citations
16.
How, Jeffrey, et al.. (2018). Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. Minerva Obstetrics and Gynecology. 70(2). 194–214. 50 indexed citations
17.
How, Jeffrey, Susie Lau, Shannon Salvador, et al.. (2017). Unexpected locations of sentinel lymph nodes in endometrial cancer. Gynecologic Oncology. 147(1). 18–23. 31 indexed citations
18.
How, Jeffrey, Walter H. Gotlieb, Joshua Z. Press, et al.. (2015). Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer. Gynecologic Oncology. 137(3). 436–442. 124 indexed citations
19.
How, Jeffrey, Jeremie Abitbol, Susie Lau, Walter H. Gotlieb, & Haim A. Abenhaim. (2015). The Impact of Qualitative Research on Gynaecologic Oncology Guidelines. Journal of Obstetrics and Gynaecology Canada. 37(2). 138–144. 2 indexed citations
20.
Lau, Susie, Sylvie Aubin, Zeev Rosberger, et al.. (2014). Health-Related Quality of Life Following Robotic Surgery: A Pilot Study. Journal of Obstetrics and Gynaecology Canada. 36(12). 1071–1078. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joel Clemmer Breakdown of academic impact, for papers by Marika C. Stenfert Kroese Breakdown of academic impact, for papers by Neil S. Horowitz Breakdown of academic impact, for papers by Alessia Aloisi Breakdown of academic impact, for papers by Marilyn Huang Breakdown of academic impact, for papers by Stephanie L. Wethington Breakdown of academic impact, for papers by Nicolò Bizzarri Breakdown of academic impact, for papers by N.R. Abu-Rustum Breakdown of academic impact, for papers by Shannon Salvador Breakdown of academic impact, for papers by Nawar Latif
Rankless by CCL
2026